Hero image for The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket
Webinar

The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket

Webinar
The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket

Consumer Behavior

Cover image 1 for The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket

The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket

In partnership with Bramble Intelligence

One in eight GB households now has someone taking a GLP-1 drug. Join NIQ and Bramble Intelligence as we unpack new household panel data revealing exactly what’s winning, what’s losing, and what it means for the future of food and beverage industry. 

Register now

GLP-1 drugs are no longer a niche story. They are changing what people buy, how often they shop, and where they spend, at a pace no modern medicine has matched. 

11.8% of GB households – around 3.3 million – now have at least one GLP-1 user. Households on these drugs are already spending 1.9% less on groceries than everyone else. Underneath that headline number there are gaps between category winners and losers.  

Weight-loss drugs suppress hunger, prolong fullness and are increasingly linked to changes in shopper behaviour. This cohort is a group of fast-growing shoppers whose habits don’t yet match anything on the shelf today. 

  • Uptake is broad-based, not confined to the affluent 
  • Six in ten users do their household’s main shop, meaning the effect reaches roughly 4.1 million people who’ve never taken the drug themselves 
  • The US is running two to three years ahead of GB on adoption, offering an early look at where the GB basket is headed next 

This isn’t a future problem to plan for. It’s already showing big shifts in the data. 

A first look at the new report

The report is powered by NIQ’s Consumer panel intelligence, from grocery purchase data and survey responses, bringing together comprehensive analysis of the effects across multiple categories.

  • A first-of-its-kind dataset. Built on grocery purchase and survey data from GB households, directly comparing GLP-1 user households against non-users over 26-week periods
  • Category-level precision. Granular spend and volume shifts across food, drink, personal care, pet and baby
  • Global context. Adoption trajectories benchmarked against the US, Canada, Australia, France, Germany, Spain and Brazil.
  • A joint NIQ x Bramble Intelligence view, combining NIQ’s comprehensive panel and purchase data with Bramble’s category and food system intelligence.

Register now

Why you should attend 

What you’ll walk away with

In this session, you’ll learn how to:

  • See where grocery spend is really shifting – the categories quietly gaining and losing as GLP-1 adoption scales
  • Understand the four unmet needs now sharing demand: less work, managing side effects, getting more from less, and new indulgences
  • Benchmark GB adoption against global markets, and anticipate what’s coming next
  • Apply the findings to your category and brand with a clear view of where the current shelf offer is, and isn’t, meeting this group’s needs

This webinar is built for:

  • Category and brand teams across FMCG looking to assess exposure and opportunities 
  • Insights and strategy professionals who need a data-led view of fast-moving consumer shifts 
  • Commercial and trade teams building the case for reformulation, innovation or trade investment  
  • Retail teams rethinking assortment, space and promotion in light of changing basket composition 

Cover image 1 for The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket

What We’ll Cover 

  • The mainstream shift. How fast GLP-1 adoption is really moving in Great Britain, who’s taking these drugs and why this is a whole-household story, not just an individual one 
  • Consumers purchasing patterns. The four consumer needs driving change, and how this is leading to a reprioritsation of products within categories 
  • The redefining of convenience. Why spend is moving into convenience formats  
  • Where next. What the US trajectory tells us about where adoption across markets and baskets is headed in the future. 

Meet the Speakers

Inline image 1 for The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket
Inline image 2 for The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket
Inline image 3 for The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket
Inline image 4 for The GLP-1 Effect: How weight-loss drugs are reshaping the shopping basket

Join the discussion

Pick a time that suits you best

Register now